Clinical Trials
16
Active:14
Completed:2
Trial Phases
2 Phases
Phase 1:15
Phase 2:1
Drug Approvals
2
FDA:2
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
15 (93.8%)Phase 2
1 (6.3%)A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
Phase 1
Completed
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- BeiGene USA, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT03150862
- Locations
- 🇺🇸
Center For Neurosciences, Tucson, Arizona, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸University of California At San Francisco, San Francisco, California, United States
News
No news found